A new percutaneous technique for establishing venous bypass access in orthotopic liver transplantation. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


A new percutaneous technique for establishing venous bypass access in orthotopic liver transplantation.

J Cardiothorac Vasc Anesth. 1994 Feb;8(1):58-60. Unique Identifier : AIDSLINE MED/94220635
Oken AC; Frank SM; Merritt WT; Fair J; Klein A; Burdick J; Thompson S; Beattie C; Department of Anesthesiology, Johns Hopkins Hospital, Baltimore,; MD 21205.


Abstract: Partial veno-venous bypass (VVB) is commonly used in orthotopic liver transplantation (OLT). Venous access for blood return during VVB classically uses a surgical cutdown on the left axillary vein (LAV), which may prolong operating time and can be associated with significant complications. The authors have developed an alternative means of establishing venous access whereby the anesthesia team places 8.5F venous cannulae preoperatively in one or two vessels (internal jugular, antecubital, or subclavian) percutaneously using the Seldinger technique. These cannulae then serve to accept venous return from below the diaphragm via a centrifugal pump. The aim fo the present study was to compare the hemodynamic profiles obtained during the anhepatic phase of OLT in patients in whom either a conventional LAV catheter (group 1) or percutaneous catheters (group 2) were used for return flow from a centrifugal pump. There were no identifiable complications related to venous access in either group of patients. Total operating room time was 800 +/- 30 minutes in group 1 and 720 +/- 40 minutes in group 2 (P = 0.17). Hemodynamic parameters were determined from continuous strip chart recordings of arterial, right atrial, and inferior vena caval (IVCP) pressures. Cardiac output (CO) was measured by thermodilution whereas pump flow was determined by an electromagnetic probe. Renal perfusion pressure (RPP) was calculated as the difference between mean arterial pressure (MAP) and IVCP. Bypass pump flow was greater, but not significantly different between group 1 (3.0 +/- 0.2 L/min) and group 2 (2.4 +/- 0.2 L/min) (P = 0.09).(ABSTRACT TRUNCATED AT 250 WORDS)
Keywords: Axillary Vein/SURGERY Blood Pressure Blood Transfusion Cardiac Output Catheterization, Central Venous *Catheters, Indwelling Central Venous Pressure Comparative Study Elbow/BLOOD SUPPLY Femoral Vein/SURGERY Heart Rate Hepatic Artery/SURGERY Human Jugular Veins/SURGERY *Liver Transplantation Oxygenators Portal Vein/SURGERY Subclavian Vein/SURGERY Time Factors Veins/SURGERY Vena Cava, Inferior/SURGERY *Venous Cutdown JOURNAL ARTICLEKWDaxillaryvein/surgerybloodpressurebloodtransfusioncardiacoutputcatheterization,centralvenousKWDcatheters,indwellingcentralvenouspressurecomparativestudyelbow/bloodsupplyfemoralvein/surgeryheartratehepaticartery/surgeryhumanjugularveins/surgeryKWDlivertransplantationoxygenatorsportalvein/surgerysubclavianvein/surgerytimefactorsveins/surgeryvenacava,inferior/surgeryKWDvenouscutdownjournalarticle
940830
M9480761

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .